Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
about
Taxane-containing regimens for metastatic breast cancerLocally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerInference of synergy/antagonism between anticancer drugs from the pooled analysis of clinical trialsA phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol.Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialSurvivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer.Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
P2860
Q24187214-1D0715F5-1158-4CB3-A5AD-854F6E725AB0Q30657649-BF74A313-4666-48F4-BBEC-810D63945C3EQ33838622-A82EC3C6-CDDD-40A1-A6E4-BEF46D808625Q34674722-C5D22EE6-2C2D-491C-AE37-7610F4C59262Q34768518-5EB7D55C-B84C-4FBB-98FF-C16420C8EF4CQ35125726-CBB8FA4B-8C78-41E2-BA0B-79EBAA1BA652Q36322815-4DAA00F4-5BDF-4CFE-A603-0F4E83B5CD58Q37560772-3116C9C4-7E75-4A50-8525-82A04F7DA9ACQ38245797-1F1B319F-9DEA-4036-8229-BDF7B39E9CFAQ40617502-B7A83C46-E75A-40D7-9A7E-4F70AA9107F4Q50908788-DC8AE484-EA92-4280-AFBA-6848A839296B
P2860
Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@ast
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@en
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@nl
type
label
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@ast
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@en
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@nl
prefLabel
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@ast
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@en
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@nl
P2093
P2860
P31
P921
P1476
Meta-analysis of phase III tri ...... py in metastatic breast cancer
@en
P2093
Caterina Fanizza
Corrado Ficorella
Maurizio Belfiglio
Stefano Iacobelli
P2860
P2888
P356
10.1007/S00432-011-1091-0
P407
P577
2012-02-01T00:00:00Z
P5875
P6179
1020075283